A team of researchers sought to determine the efficacy of psilocybin as an antidepressant compared with placebo or ...

The search for a universal flu vaccine has been long and fraught with false starts and dead ends. For more than five years, ...

Leading oncology drug developers raise $67 million in funding to target cancer's vulnerability to oncogene overactivation.

Moonwalk Biosciences launched earlier this year, crashing the epigenome editing bash. So it is not surprising that the ...

Novartis has agreed to acquire Mariana Oncology for up to $1.75 billion, the companies said today, in a deal that would ...

Despite being one of the most common and well-known neurodegenerative diseases, multiple sclerosis (MS) remains difficult to treat. However, new research from scientists at Cincinnati Children’s ...

For the first time the developmental stages of the deadliest human malaria parasite, Plasmodium falciparum, have been mapped in high resolution, allowing scientists to better understand this ...

Future research could identify drugs that can target this newfound brain circuit to help treat a vast range of immune ...

The Producer service offers customers a second option for accessing Asimov's technology for the cell and gene therapy ...

Scientists at Harvard Medical School have used technology from Opentrons Labworks to streamline sample preparation.

Years from now, when we look back on today’s vaccine development scene, we might say it was almost as consequential as the ...

Vaccine harnesses multi-lamellar LP aggregates (LPA) that can simultaneously function as vaccines and as immunomodulating agents.